Sandbox Financial Partners’s Gilead Sciences GILD Stock Holding History

Sandbox Financial Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$293K	Sell	2,104 -51	-2%	-$7.14K	0.08%	92
2025 Q4	$264K	Buy	2,155 +1	+0%	+$122	0.07%	101
2025 Q3	$239K	Sell	2,154 -128	-6%	-$14.5K	0.07%	107
2025 Q2	$253K	Sell	2,282 -1	-0%	-$106	0.08%	100
2025 Q1	$256K	Buy	2,283 +2	+0.1%	+$206	0.09%	96
2024 Q4	$211K	Buy	+2,281	New	+$205K	0.07%	104
2022 Q3	–	Sell	-3,500	Closed	-$216K	–	89
2022 Q2	$216K	Hold	3,500	–	–	0.15%	77
2022 Q1	$208K	Sell	3,500 -500	-13%	-$32K	0.12%	89
2021 Q4	$290K	Buy	+4,000	New	+$276K	0.18%	71

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Sandbox Financial Partners's GILD Position: Q1 2026 in Review

Sandbox Financial Partners reduced its Gilead Sciences (GILD) stake by 2.4% in Q1 2026, selling an estimated $7.14K and leaving 2,104 shares worth $293K. The position accounts for 0.08% of the portfolio, ranked #92.

Sandbox Financial Partners first reported a position in GILD in Q4 2021 and has held it in 9 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Sandbox Financial Partners held 2,104 shares of Gilead Sciences worth $293K as of Q1 2026.
Sandbox Financial Partners sold 51 Gilead Sciences shares in Q1 2026, an estimated $7.14K.
Gilead Sciences made up 0.08% of Sandbox Financial Partners's portfolio in Q1 2026, its #92 holding.
Sandbox Financial Partners first reported a position in Gilead Sciences in Q4 2021 and has held it in 9 quarters since.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Sandbox Financial Partners's 13F filing for Q1 2026, filed 8 Apr 2026.